Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd. was formerly known as Chengdu Isotope Application Technology Research Institute of China Nuclear Power Research and Design Institute (established in 1992), which was restructured and established in July 2001. The company is located in the national high-tech development zone "Chengdu High tech Development Zone", and the factory is located in the Southwest Airport Economic Development Zone. It is a Sichuan Provincial Enterprise Technology Center Enterprise and a national high-tech enterprise. The company has a 6000m2 standard factory building and has become a GMP certified enterprise in the field of radiopharmaceuticals in China. The enterprise specializes in the research of radioactive drug technology, product development, production and sales, technical consulting and technical services. We have specialized drug development institutions, chemical and biological research laboratories, quality control laboratories, radiochemistry laboratories, drug clinical observation and treatment centers and other experimental bases related to scientific research and development, GMP standard factories, and a nationwide sales network.

The company is a supporting unit of Chengdu Radiopharmaceuticals Engineering Technology Research Center and Chengdu Radiopharmaceuticals Industry University Research Joint Laboratory, and a co construction unit of Sichuan Isotope Engineering Technology Center. The company is a doctoral and master's training center for the "Nuclear Technology and Applications" major at China Nuclear Power Research and Design Institute, with 2 doctoral supervisors and 5 master's supervisors. We have technological advantages and talent reserves in the preparation of medical radioactive isotopes, research and development of innovative radioactive drugs, application of radioactive drugs in medical devices, and research on innovative chemical drugs for bone related diseases.

The company has successfully developed 9 types of radioimmunoassay diagnostic kits and in vivo imaging diagnostic kits, as well as an innovative drug for the treatment of rheumatoid arthritis and bone diseases, technetium [99Tc] methylene diphosphonate injection (trade name: "Yunke"). Among them, "Yunke" is one of the radioactive drugs with independent intellectual property rights in China and has obtained the "National Key New Product" certificate. The company has successively obtained 11 national invention patents, 3 European and American invention patents, 1 China Patent Excellence Award, and 1 second prize for ministerial level scientific and technological progress.